An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis

By sjmartinez • June 20, 2024

Shah A, Tabibian J, Buness C, Holtmann GJ. An 'Adaptive Treatment Strategy' for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis. Dig Dis Sci. 2024 Jun 19. doi: 10.1007/s10620-024-08497-4. Epub ahead of print. PMID: 38896361.

Tags: Adaptive treatment strategy, Digestive Diseases, Olive View DoM, Oral vancomycin, Orphan disease, Primary sclerosing cholangitis, Publications, rare disease, Therapeutic decision-making

Corrigendum to “Subchronic inhalation exposure to ultrafine particulate matter alters the intestinal microbiome in various mouse models” [Environ. Res. 248 (2024) 118242]

Chang C, Gupta R, Sedighian F, Louie A, Gonzalez DM, Le C, Cho JM, Park SK, Castellanos J, Ting TW, Dong TS, Arias-Jayo N, Lagishetty[...]

Increasing Goals of Care Discussions Among Veterans with Cirrhosis: A Veterans Health Administration Quality Improvement Initiative

Patel AA, O'Leary JG, Bajaj JS, Prause N, Hannum R, Noll A, Cheung R, Giustini AB, Jakab SS, Nobbe A, Patton H, Perumalswami P, Spoutz[...]

Mechanisms and therapeutic insights into MASH-associated fibrosis

Zhu Y, Cai B. Mechanisms and therapeutic insights into MASH-associated fibrosis. Trends Endocrinol Metab. 2025 Sep 26:S1043-2760(25)00196-1. doi: 10.1016/j.tem.2025.09.004. Epub ahead of print. PMID: 41015698.